Hematological Malignancy

• CLINICAL_TRIALS research · 2026-04-07
  Clinical Trial Update: SG301 Safety Study in Subjects With Relapsed or Refractory Multiple Myeloma and Other Hematological Malignancies [Phase 1]

  Phase 1 safety study SG301 in relapsed or refractory multiple myeloma and other hematologic malignancies is currently active but not recruit…

• CLINICAL_TRIALS research · 2025-11-24
  Clinical Trial Update: DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations [Phase 2, Phase 3]

  An ongoing DETERMINE trial (arm 06) investigates capmatinib for MET-dysregulated cancers, with Phase 2/3 testing and current recruitment.

• CLINICAL_TRIALS research · 2024-09-19
  Clinical Trial Update: Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological Tumors [Phase 2]

  A Phase 2 study evaluating thymalfasin and recombinant human interleukin-2 injections for lymphocytopenia in patients with malignant hematol…

• CLINICAL_TRIALS research · 2024-07-01
  Clinical Trial Update: Integrated Multiomics and Multilevel Characterization of Haematological Disorders and Malignancies

  This document provides an update on a clinical trial focused on integrated multiomics and multilevel characterization of hematologic disorde…

• CLINICAL_TRIALS research · 2018-07-23
  Clinical Trial Update: Impact of a Monitoring Device for Patients With Cancer Treated Using Oral Therapeutics

  A clinical trial update describes the impact of a monitoring device for cancer patients treated with oral therapies; the study status is cur…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2016-09-14
  Clinical Trial Update: Effects of Exercise on Allogeneic Stem Cell Transplant [NA]

  Clinical trial update on the effects of exercise in patients undergoing allogeneic stem cell transplantation for hematological malignancies;…